This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/523203-vietnam-woman-dies-covid-astrazeneca-vaccine/

The article has changed 3 times. There is an RSS feed of changes available.

Version 1 Version 2
Woman in Vietnam dies from anaphylaxis after receiving AstraZeneca's Covid-19 vaccine – health ministry Woman in Vietnam dies from anaphylaxis after receiving AstraZeneca's Covid-19 vaccine – health ministry
(about 1 month later)
A 35-year-old female medical worker in Vietnam has died from anaphylaxis after being injected with AstraZeneca's Covid-19 vaccine, in a “very rare” case of adverse reaction to the drug, the country's health ministry has announced.A 35-year-old female medical worker in Vietnam has died from anaphylaxis after being injected with AstraZeneca's Covid-19 vaccine, in a “very rare” case of adverse reaction to the drug, the country's health ministry has announced.
The woman, who was a member of staff at the Tan Chau Regional General Hospital in the southern An Giang province, died from anaphylaxis on Friday. She received her first dose of the Anglo-Swedish jab at the hospital on Thursday morning and subsequently died from anaphylactic shock.The woman, who was a member of staff at the Tan Chau Regional General Hospital in the southern An Giang province, died from anaphylaxis on Friday. She received her first dose of the Anglo-Swedish jab at the hospital on Thursday morning and subsequently died from anaphylactic shock.
“This is a very rare case in the vaccination against Covid-19,” the ministry said in the statement.“This is a very rare case in the vaccination against Covid-19,” the ministry said in the statement.
As of Friday, more than 747,800 people in Vietnam had been administered AstraZeneca's Vaxzevria vaccine, according to health ministry data.As of Friday, more than 747,800 people in Vietnam had been administered AstraZeneca's Vaxzevria vaccine, according to health ministry data.
Confirmation of the death comes as Vietnam, which has previously contained outbreaks of the coronavirus quickly, is currently facing a slight uptick in Covid-19 cases, including in the capital Hanoi.Confirmation of the death comes as Vietnam, which has previously contained outbreaks of the coronavirus quickly, is currently facing a slight uptick in Covid-19 cases, including in the capital Hanoi.
On Friday, the southeast Asian country registered 46 new infections, with 24 in Hanoi, according to the health ministry. The latest cases bring Vietnam's total so far in the pandemic to 3,137, with 161 cases discovered since the country's most recent outbreak started on April 27.On Friday, the southeast Asian country registered 46 new infections, with 24 in Hanoi, according to the health ministry. The latest cases bring Vietnam's total so far in the pandemic to 3,137, with 161 cases discovered since the country's most recent outbreak started on April 27.
Anaphylaxis has been reported as a potential side effect of AstraZeneca's vaccine by the drug regulatory authorities in the EU and in the UK.Anaphylaxis has been reported as a potential side effect of AstraZeneca's vaccine by the drug regulatory authorities in the EU and in the UK.
Some 590 cases of allergic reactions associated with anaphylaxis or anaphylactoid response had been reported in the UK as of May 6, according to the country's Medicines and Healthcare products Regulatory Agency (MHRA). By April 28, an estimated 22.6 million people in the UK had received a first dose of AstraZeneca's vaccine, while 5.9 million had received both doses, the agency said.Some 590 cases of allergic reactions associated with anaphylaxis or anaphylactoid response had been reported in the UK as of May 6, according to the country's Medicines and Healthcare products Regulatory Agency (MHRA). By April 28, an estimated 22.6 million people in the UK had received a first dose of AstraZeneca's vaccine, while 5.9 million had received both doses, the agency said.
Think your friends would be interested? Share this story!Think your friends would be interested? Share this story!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.